Invalid Symbol

Stock Research for AERI

AERI
Current Price

$


Latest Update:

High
$
Low
$
Close
$
Volume
 
  

Featured Broker: TradeStation

Get the due diligence for another stock.

 

AERI Stock Chart & Research Data

The AERI chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the AERI chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.


 


AERI Due diligence Resources & Stock Charts

The AERI stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.

The Four Most Popular Resources

CNN View AERI Detailed Price Forecast - CNN Money CNN View AERI Detailed Summary - Google Finance
Yahoo View AERI Detailed Summary - Yahoo! Finance Zacks View AERI Stock Research & Analysis - Zacks.com


Stock Analysis

TradeIdeas View AERI Trends & Analysis - Trade-Ideas Barrons View AERI Major Holders - Barrons
NASDAQ View AERI Call Transcripts - NASDAQ Seeking View AERI Breaking News & Analysis - Seeking Alpha
Spotlight View AERI Annual Report - CompanySpotlight.com OTC Report View AERI OTC Short Report - OTCShortReport.com
TradeKing View AERI Fundamentals - TradeKing Charts View AERI SEC Filings - Bar Chart
WSJ View Historical Prices for AERI - The WSJ Morningstar View Performance/Total Return for AERI - Morningstar
MarketWatch View the Analyst Estimates for AERI - MarketWatch CNBC View the Earnings History for AERI - CNBC
StockMarketWatch View the AERI Earnings - StockMarketWatch MacroAxis View AERI Buy or Sell Recommendations - MacroAxis
Bullish View the AERI Bullish Patterns - American Bulls Short Pains View AERI Short Pain Metrics - ShortPainBot.com


Social Media Mentions

StockTwits View AERI Stock Mentions - StockTwits PennyStocks View AERI Stock Mentions - PennyStockTweets
Twitter View AERI Stock Mentions - Twitter Invest Hub View AERI Investment Forum News - Investor Hub
Yahoo View AERI Stock Mentions - Yahoo! Message Board Seeking Alpha View AERI Stock Mentions - Seeking Alpha




Financial & Transaction Holdings

SECform4 View Insider Transactions for AERI - SECform4.com Insider Cow View Insider Transactions for AERI - Insider Cow
CNBC View AERI Major Holdings Summary - CNBC OTC Markets View Insider Disclosure for AERI - OTC Markets
Yahoo View Insider Transactions for AERI - Yahoo! Finance NASDAQ View Institutional Holdings for AERI - NASDAQ


Stock Charts

FinViz View AERI Stock Insight & Charts - FinViz.com StockCharts View AERI Investment Charts - StockCharts.com
BarChart View AERI Stock Overview & Charts - BarChart Trading View View AERI User Generated Charts - Trading View


Latest Financial News for AERI

Aerie Pharmaceuticals to Announce Fourth Quarter and Full Year 2017 Financial Results and Host Conference Call on Wednesday, February 28, 2018
Posted on Wednesday February 21, 2018

Aerie Pharmaceuticals, Inc. , announced today that its fourth quarter and full year 2017 financial results will be released after the market closes on Wednesday, February 28, 2018.


See what the IHS Markit Score report has to say about Aerie Pharmaceuticals Inc.
Posted on Tuesday February 20, 2018

Aerie Pharmaceuticals Inc NASDAQ NMS:AERI


Aerie Pharmaceuticals Announces Appointment of John LaRocca as General Counsel
Posted on Tuesday February 20, 2018

Aerie Pharmaceuticals, Inc. , an ophthalmic pharmaceutical company focused on the discovery, development and commercialization of first-in-class therapies for the treatment of patients with open-angle glaucoma and other diseases of the eye, today announced the appointment of John LaRocca as General Counsel, reporting to Vicente Anido, Jr., Ph.D., Aerie’s Chairman and Chief Executive Officer.


Aerie Pharmaceuticals Announces Appointment of Scott Cassady as Regional Sales Director for the Central Region
Posted on Monday February 12, 2018

Aerie Pharmaceuticals, Inc. , an ophthalmic pharmaceutical company focused on the discovery, development and commercialization of first-in-class therapies for the treatment of patients with open-angle glaucoma and other diseases of the eye, today announced the appointment of Scott Cassady as Regional Sales Director for the Central Region, reporting to Gary Menichini, Aerie’s Vice President of Sales....


Aerie Pharmaceuticals Announces Appointment of John LaRocca as General Counsel
Business Wire (press release) - Feb 20, 2018
DURHAM, N.C.--(BUSINESS WIRE)--Aerie Pharmaceuticals, Inc. (NASDAQ:AERI), an ophthalmic pharmaceutical company focused on the discovery, development and commercialization of first-in-class therapies for the treatment of patients with open-angle ...
Today Aerie Pharmaceuticals Inc (NASDAQ:AERI) Reported Decrease in Shorted Shares - BZ Weekly
Aerie Pharmaceuticals to Announce Fourth Quarter and Full Year 2017 Financial ... - PharmiWeb.com (press release)

A New Kind of Stock Chart: Aerie Pharmaceuticals Inc (NASDAQ:AERI) Critical ...
CML News - 11 hours ago
This is a real time view of the critical technical pivot points for Aerie Pharmaceuticals Inc (NASDAQ:AERI) . The technical pivot points we look at all surround the stock price movement from the last 10-trading days through the last year.

EPS for Aerie Pharmaceuticals, Inc. (AERI) Expected At $-1.47
Frisco Fastball - 11 hours ago
Royal Financial Bank Of Canada invested 0% of its portfolio in Aerie Pharmaceuticals, Inc. (NASDAQ:AERI). Point72 Asia (Hong Kong) Ltd owns 230 shares.
$-1.47 EPS Expected for Aerie Pharmaceuticals, Inc. (AERI) - BZ Weekly

Aerie Pharmaceuticals Announces Appointment of Tad Heitmann as Head of ...
Business Wire (press release) - Feb 1, 2018
IRVINE, Calif.--(BUSINESS WIRE)--Aerie Pharmaceuticals, Inc. (NASDAQ:AERI), an ophthalmic pharmaceutical company focused on the discovery, development, and commercialization of first-in-class therapies for the treatment of patients with open-angle ...

Enter a stock symbol to view the stock details.